2021 - Dass-167

The code DASS-167 refers to a specific informative session and task within a larger neurocognitive research study. This session serves as the entry point for participants, designed to ensure they understand the project's rationale, objectives, and procedures before moving on to treatment and assessment. The Role of DASS-167 in Research

In the context of the study, DASS-167 is an Informative Session that takes place during the first week. Its primary functions include:

Participant Orientation: Providing a clear explanation of why the intervention is being conducted and what the research team hopes to achieve. DASS-167

Procedure Walkthrough: Outlining the roadmap for the following weeks, which include pretreatment assessments like fMRI scans and neurocognitive intervention sessions.

Informed Consent: Ensuring that all participants have the necessary information to provide written consent, a critical ethical requirement for clinical research. Broader Scientific Context The code DASS-167 refers to a specific informative

The study containing this session often utilizes standardized screening instruments such as the DASS-21 (Depression, Anxiety, and Stress Scale) to establish baseline psychological states. These scores are later used to measure the effectiveness of interventions like Intermittent Theta Burst Stimulation (iTBS) and inhibitory control training, which aim to help individuals manage food intake problems or other cognitive challenges.

The DASS-167, also known as the Depression Anxiety Stress Scales, is a psychological assessment tool designed to measure the levels of depression, anxiety, and stress in individuals. Developed by Syd Lovibond and Peter Lovibond in 1995, this self-report questionnaire has become a widely used instrument in both research and clinical settings. Event: { event_id, source_id, timestamp, payload: object }

Use and Benefits

The DASS-21 is beneficial for both researchers and clinicians due to its brevity, ease of administration, and scoring. It allows for a quick and efficient assessment of emotional distress across three dimensions. The information obtained can guide treatment planning, provide a baseline measure of symptom severity, and help in monitoring treatment outcomes over time.

Data model (concise)

Event: { event_id, source_id, timestamp, payload: object }
Score: { score_id, event_id, rule_version, score_value, reason_codes[], computed_at }
Audit record: { audit_id, actor, action, target, timestamp, diff }

Introduction

The DASS-167 seems to be a less commonly referenced assessment tool compared to the well-established DASS-21 and DASS-42, which are widely used in psychological research and clinical settings. The standard DASS assessments are designed to measure the negative emotional states of depression, anxiety, and stress.

Usage

Clinicians and researchers use these assessments to:

Screen for depression, anxiety, and stress in populations.
Monitor changes over time in response to interventions.
Assist in differential diagnosis.

Clinical Application and Interpretive Guidelines

The DASS-21 is used in various clinical settings to screen for depression, anxiety, and stress and to monitor the progress of patients undergoing treatment. The scores on each subscale can range from 0 to 21, and there are established cut-off scores to help classify the severity of depression, anxiety, and stress:

Normal: 0-9 for Depression, 0-7 for Anxiety, and 0-14 for Stress.
Mild: 10-13 for Depression, 8-9 for Anxiety, and 15-18 for Stress.
Moderate: 14-19 for Depression, 10-14 for Anxiety, and 19-25 for Stress.
Severe: 20-27 for Depression, 15-19 for Anxiety, and 26-33 for Stress.
Extremely Severe: 28+ for Depression, 20+ for Anxiety, and 34+ for Stress.

Deliverables

Technical specification document (this file + detailed schemas).
Implementation plan and sprint backlog.
API reference and OpenAPI spec.
CI/CD pipeline and deployment manifests (Helm/K8s).
Test suite (unit, integration, load tests).
Monitoring dashboards and runbook.